Showing results (941-950 of 1,116) with videos related to

Sort By:
Pageof 112
Kyobu Geka. the Japanese Journal of Thoracic Surgery|August 24, 2001
[Translocation of the aortic valve for aortic stenosis in a patient with severe calcification in the aortic root: report of a case]T Manabe, K Imoto, Y Ichikawa, et al.
Gastroenterology|December 13, 2000
Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's diseaseT Kanai, M Watanabe, A Okazawa, et al.
The Journal of Rheumatology|October 1, 1990
Adherent synovial cells from nonrheumatoid arthritis do not release interleukin 1 beta and prostaglandin E2 spontaneously in longterm cultureM Goto, M Okamoto, M Sasano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1993
[A study of toxicities and complications observed in alternating non-cross-resistant chemotherapy (CAMBO-VIP) for non-Hodgkin's lymphoma]F Maruyama, K Ezaki, M Okamoto, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|July 1, 1993
[Brain protection on the aortic arch replacement--with deep hypothermic selective cerebral perfusion via right axillary artery]Y Noguchi, Y Naito, K Fujiwara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1993
[Rearrangements of immunoglobulin light chain and heavy chain constant region genes in B-cell malignancies]F Maruyama, T Ino, H Miyazaki, et al.
Diabetologia|May 1, 1996
Insulin-induced activation of phosphoinositide 3-kinase in Fao cellsT Hayashi, M Okamoto, Y Yoshimasa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1993
[Experimental study on comparative efficacy of hepatic arterial injection of anticancer agent under temporary occlusion of portal vein]I Shirosaki, K Tazawa, T Kushibuchi, et al.
Clinical Transplantation|June 12, 2004
An autopsy case of bacterial septic shock 12 years following ABO-incompatible renal transplantationM Okamoto, Y Omori, M Ichida, et al.
Leukemia Research|January 1, 1995
Interleukin-1 beta (IL-1 beta) and acute leukemia: in vitro proliferative response to IL-1 beta, IL-1 beta content of leukemic cells and treatment outcomeK Ezaki, M Tsuzuki, I Katsuta, et al.
Pageof 112